Condition: Rectal Cancer · Sponsor: Sun Yat-sen University
Comparative analysis of the clinical efficacy between primary Total Mesorectal Excision (TME) surgery and neoadjuvant chemotherapy combined with TME surgery for low-risk locally advanced rectal cancer. Randomly enrolling eligible patients into either the control group receiving neoadjuvant chemotherapy combined with TME surgery or the experimental group receiving primary TME surgery, and subsequently comparing the clinical outcomes of the two groups
This description comes directly from the study's public registry record.
Huashan Liu, MD. PhD · +8613560309975 · liuhshan@mail2.sysu.edu.cn
Ziwei Zeng, MD,PhD · +8615521161750 · zengzw@mail2.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| Daping Hospital, Amy Medeical Univerisity | Chongqing, Chongqing Municipality, China | Recruiting |
| Sun yat-sen University, the Sixth Affiliated Hospital | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of University of South China | Hengyang, Hunan, China | Recruiting |
| Shengjing Hospital of China Medical University | Shenyang, Liaoning, China | Recruiting |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an, Shaanxi, China | Recruiting |
| The Affiliated Nanchong Central Hospital of North Sichuan Medical College | Nanchong, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05984485